After having been in the investing world for more than 25 years from private banking and investment management to private and venture capital; I have pretty much "been there and done that" at one point or another. I am currently a partner at RIA Advisors in Houston, Texas. The majority of my time is spent analyzing, researching and writing commentary about investing, investor psychology and macro-views of the markets and the economy. My thoughts are not generally mainstream and are often contrarian in natur ...

It's not uncommon to feel like you're behind on retirement savings. But you should know that if you're not even midway through your career yet, there's plenty of time to play catch up if your IRA or 401(k) could use a boost. That said, if your savings don't seem to be growing, there could be a reason why. Here are three things that may be stopping you from supercharging your IRA or 401(k). Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, calle ...

The company also reported regulatory approvals during the quarter for zanidatamab monotherapy in Canada and the United Kingdom for second-line biliary tract cancer. Galbraith framed the broader zanidatamab program as a foundation for future milestone and royalty streams. He said Zymeworks expects the program could translate into regulatory milestone payments for global approvals in GEA of up to $440 million, plus an additional $89 million collectively from Jazz and BeiGene upon approval in a third indicatio ...

Keveyis: Fourth quarter revenue was $12.8 million and full-year revenue was $47.6 million. Management said Keveyis continued to outperform expectations, supported by an increase in the average number of patients on therapy, and noted the role of patient support for people living with primary periodic paralysis.Gvoke: Fourth quarter revenue was $24.6 million and full-year revenue was $94.1 million. Shannon said Gvoke posted 14% growth for the year, supported by broad access and alignment with treatment guide ...

Looking ahead, management reiterated that 2026 will be a major investment year at Kinetic. Bullington said the company is targeting:Bullington said Kinetic consumer fiber revenue rose 24% year-over-year in the quarter, and total Kinetic fiber subscribers increased 20% from the prior-year period. Kinetic’s fiber penetration was 29% in the fourth quarter, up 30 basis points sequentially and 150 basis points year-over-year, while fiber ARPU increased 5% year-over-year.Chief Financial Officer Paul Bullington sa ...

Payments: Total payment volume (TPV) grew 14% year over year in the fourth quarter and 19% for full-year 2025, in line with prior guidance of around 20%. Transaction volumes rose 12% in Q4 and 14% for the year. Ferguson said take rate dilution continued as lower take-rate products such as Kaspi Pay and Kaspi B2B grew in mix, resulting in revenue growth of 7% in Q4 and 12% for the year. Net income grew 4% in Q4 and 13% for full-year 2025, with Q4 impacted in part by costs tied to the Alaqan launch and scalin ...

Fourth-quarter results showed a rebound in AAON-branded sales, which Thompson said rose 9.5% year-over-year. Tobolski added that the increase was supported by a 42% rise in Alpha Class heat pump sales, calling it the strongest quarterly AAON-branded growth since the second quarter of 2024. AAON-branded bookings in the quarter increased 20% year-over-year, and management said AAON backlog rose 61% from the prior-year period.Tobolski said AAON-branded performance held up despite a 16% decline in overall indus ...

Sim also reiterated the company’s approach to taking on full risk only when economics and operational readiness are aligned. Astrana said it remains on track for approximately 80% of revenue and more than 36% of its own membership to be in full-risk arrangements by the end of the first quarter of 2026. Management noted that several full-risk contracts expected to begin in mid-2025 instead commenced in early 2026 as part of a coordinated implementation process.At year-end, about 19% of total revenue came fro ...

Procter & Gamble has been paying dividends for more than a century. In 2026, it made one of its biggest shareholder commitments ever. The Dow Jones Dividend King is the consumer goods giant behind Tide, Pampers, Gillette, and dozens of other household brands. It recently disclosed plans to pay out roughly $10 billion in dividends in fiscal year 2026 alone. Moreover, P&G (PG) expects to buy back about $5 billion in company stock, bringing total cash returned to shareholders to $15 billion for the year. T ...

NextDecade eyes first LNG from Rio Grande Train 1 in 2027 | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]- Companies[NextDecade Corp]FollowMarch 2 (Reuters) - U.S liquefied natural gas producer NextDecade [(NEXT.O), opens new tab] said on Monday it expects the first LNG production from its first liquefaction plant, known as a train, at its Rio Grande facility in the first half of 2027.Shares of the company rose nearly 10% in morni ...